Verona Pharma plc Verona Pharma Plc : Holding(s) In Company

 
TIDMVRP 
 
 
 
 
For filings with the FCA include the annex 
 For filings with issuer exclude the annex 
 
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES(i) 
 
1. Identity of the issuer or the underlying issuer                        Verona Pharma plc 
 of existing shares to which voting rights are 
 attached: (ii) 
2 Reason for the notification (please tick the appropriate 
 box or boxes): 
An acquisition or disposal of voting rights                                         X 
An acquisition or disposal of qualifying financial 
 instruments which may result in the acquisition of 
 shares already issued to which voting rights are attached 
An acquisition or disposal of instruments with similar 
 economic effect to qualifying financial instruments 
An event changing the breakdown of voting rights 
Other (please specify): 
3. Full name of person(s) subject to the                          Aisling Capital Management LP 
 notification obligation: (iii)                                        Aisling Capital IV LP 
4. Full name of shareholder(s)                                        Aisling Capital IV LP 
 (if different from 3.):(iv) 
5. Date of the transaction and date on                                      05/19/2017 
 which the threshold is crossed or 
 reached: (v) 
6. Date on which issuer notified:                                           05/26/2017 
7. Threshold(s) that is/are crossed or                           Upward crossing of 3% threshold 
 reached: (vi, vii) 
 
 
 
 
8. Notified details: 
A: Voting rights attached to shares (viii, ix) 
Class/type of 
 shares              Situation previous 
 if possible using    to the triggering 
 the ISIN CODE        transaction                        Resulting situation after the triggering transaction 
                                       Number 
                     Number             of 
                     of                 Voting           Number                        Number of voting 
                     Shares             Rights            of shares                     rights                                           % of voting rights (x) 
                                                         Direct                        Direct (xi)            Indirect (xii)             Direct             Indirect 
 
Ordinary                                                  1,474,688                     1,474,688                                        1.41% 
 ISIN GB00B06GSH43                                        2,074,080                     2,074,080                                        1.98% 
 
  ADS 
  ISIN US9250501064 
 
B: Qualifying Financial Instruments 
Resulting situation after the triggering transaction 
                                                                                         Number of voting 
                                                                                          rights that may be 
                                                                                          acquired if the 
Type of financial        Expiration      Exercise/                                        instrument is                                      % of voting 
 instrument               date (xiii)     Conversion Period (xiv)                         exercised/ converted.                               rights 
 
 
C: Financial Instruments with similar economic effect 
 to Qualifying Financial Instruments (xv, xvi) 
Resulting situation after the triggering transaction 
Type of financial                      Expiration      Exercise/ Conversion 
 instrument            Exercise price  date (xvii)     period (xviii)                  Number of voting rights instrument refers to        % of voting rights (xix, xx) 
                                                                                                                                           Nominal            Delta 
 
 
Total (A+B+C) 
Number of voting rights                                    Percentage of voting rights 
3,548,768                                                  3.38% 
 
 
 
 
9. Chain of controlled undertakings through which 
 the voting rights and/or the 
 financial instruments are effectively held, if applicable: 
 (xxi) 
 
  Aisling Capital IV LP (which holds 3,548,768 shares 
  in the Company (3.38%)) is managed by Aisling Capital 
  Management LP. 
Proxy Voting: 
10. Name of the proxy holder: 
11. Number of voting rights proxy holder will cease 
 to hold: 
12. Date on which proxy holder will cease to hold 
 voting rights: 
 
 
 13. Additional information: 
14. Contact name:                                             Robert Wenzel 
15. Contact telephone number:                                 212-651-6374 
 
 
 
 
Note: Annex should only be submitted to the FCA not 
 the issuer 
 Annex: Notification of major interests in share (xxii) 
 
A: Identity of the persons or legal entity subject 
 to the notification obligation 
Full name                                                          Aisling Capital IV LP 
 (including legal form of legal entities) 
Contact address                                               888 7(th) Avenue, 12(th) floor 
 (registered office for legal entities)                              New York, NY 10106 
Phone number & email                                     212-651-6380 / rwenzel@aislingcapital.com 
Other useful information 
 (at least legal representative for legal persons) 
 
B: Identity of the notifier, if applicable 
Full name 
Contact address 
Phone number & email 
Other useful information 
 (e.g. functional relationship with the person or legal 
 entity subject to the notification obligation) 
 
C: Additional information 
 
For notes on how to complete form TR-1 please see 
 the FCA website. 
 
 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Verona Pharma plc via Globenewswire 
 
 
  http://www.veronapharma.com/
(END) Dow Jones Newswires
June 06, 2017 06:54 ET (10:54 GMT)
Verona Pharma (LSE:VRP)
Historical Stock Chart
From Jun 2024 to Jul 2024